|
|
| FAR 561 | Clinical Pharmacology | 3+0+0 | ECTS:7.5 | | Year / Semester | Spring Semester | | Level of Course | Second Cycle | | Status | Elective | | Department | DEPARTMENT of PHARMACOLOGY | | Prerequisites and co-requisites | None | | Mode of Delivery | Face to face, Practical | | Contact Hours | 14 weeks - 3 hours of lectures per week | | Lecturer | Prof. Dr. Ersin YARIŞ | | Co-Lecturer | Asst. Prof. Dr. Mine Kadıoğlu Duman | | Language of instruction | Turkish | | Professional practise ( internship ) | None | | | | The aim of the course: | | The course aims to provide the students a basic knowledge on the essentials of clinical pharmacology, to evaluate the ethical consideration of the subject addition to scientific methodology. |
| Programme Outcomes | CTPO | TOA | | Upon successful completion of the course, the students will be able to : | | | | PO - 1 : | give information about the basic knowledge on the essentials of clinical pharmacology, | 1 - 2 - 3 - 5 - 6 | 1,2 | | PO - 2 : | to evaluate the ethical consideration of the subject addition to scientific methodology. | 1 - 2 - 3 - 5 - 6 | 1,4 | | CTPO : Contribution to programme outcomes, TOA :Type of assessment (1: written exam, 2: Oral exam, 3: Homework assignment, 4: Laboratory exercise/exam, 5: Seminar / presentation, 6: Term paper), PO : Learning Outcome | | |
| The definition of Clinical PharmacologyDevelopment of new drugsThe kinetics of ethical codes that will be used in the clinical trials done on human-beings |
| |
| Course Syllabus | | Week | Subject | Related Notes / Files | | Week 1 | Ethics Commiittee Of Clinical Studies
| | | Week 2 | Principles of clinical pharmacology
| | | Week 3 | Development of new drugs
| | | Week 4 | Studies in preclinical phase
| | | Week 5 | Screening tests
| | | Week 6 | Phase I studies (1)
| | | Week 7 | Phase I studies (2)
| | | Week 8 | Mid-term exam | | | Week 9 | Phase II studies (1)
| | | Week 10 | Phase II studies (2)
| | | Week 11 | Phase III studies (1)
| | | Week 12 | Midterm exam | | | Week 13 | Phase III studies (2)
| | | Week 14 | Phase IV studies (1)
| | | Week 15 | Phase IV studies (2) | | | Week 16 | End-of-term exam | | | |
| Method of Assessment | | Type of assessment | Week No | Date | Duration (hours) | Weight (%) | | Mid-term exam | 8 | | 1 | 30 | | Clinic Practice | 12 | | 3 | 20 | | End-of-term exam | 16 | | 2 | 50 | | |
| Student Work Load and its Distribution | | Type of work | Duration (hours pw) | No of weeks / Number of activity | Hours in total per term | | Klinik Uygulama | 3 | 1 | 3 | | Total work load | | | 3 |
|